全文获取类型
收费全文 | 3227328篇 |
免费 | 251075篇 |
国内免费 | 7562篇 |
专业分类
耳鼻咽喉 | 45478篇 |
儿科学 | 101517篇 |
妇产科学 | 86722篇 |
基础医学 | 460819篇 |
口腔科学 | 92488篇 |
临床医学 | 303124篇 |
内科学 | 621450篇 |
皮肤病学 | 65018篇 |
神经病学 | 271060篇 |
特种医学 | 125177篇 |
外国民族医学 | 1128篇 |
外科学 | 472057篇 |
综合类 | 76388篇 |
现状与发展 | 2篇 |
一般理论 | 1361篇 |
预防医学 | 269567篇 |
眼科学 | 75004篇 |
药学 | 240916篇 |
10篇 | |
中国医学 | 6517篇 |
肿瘤学 | 170162篇 |
出版年
2018年 | 34807篇 |
2017年 | 26606篇 |
2016年 | 29110篇 |
2015年 | 33123篇 |
2014年 | 47058篇 |
2013年 | 72404篇 |
2012年 | 98279篇 |
2011年 | 104009篇 |
2010年 | 61013篇 |
2009年 | 57656篇 |
2008年 | 97510篇 |
2007年 | 103650篇 |
2006年 | 104487篇 |
2005年 | 101473篇 |
2004年 | 97178篇 |
2003年 | 93462篇 |
2002年 | 91643篇 |
2001年 | 144615篇 |
2000年 | 149470篇 |
1999年 | 126443篇 |
1998年 | 37240篇 |
1997年 | 33791篇 |
1996年 | 33228篇 |
1995年 | 32110篇 |
1994年 | 30140篇 |
1993年 | 28218篇 |
1992年 | 102228篇 |
1991年 | 99315篇 |
1990年 | 96204篇 |
1989年 | 92265篇 |
1988年 | 85732篇 |
1987年 | 84300篇 |
1986年 | 80198篇 |
1985年 | 76640篇 |
1984年 | 58254篇 |
1983年 | 49719篇 |
1982年 | 30263篇 |
1981年 | 26934篇 |
1979年 | 54333篇 |
1978年 | 38440篇 |
1977年 | 32137篇 |
1976年 | 30616篇 |
1975年 | 32089篇 |
1974年 | 39427篇 |
1973年 | 37952篇 |
1972年 | 35358篇 |
1971年 | 32800篇 |
1970年 | 30682篇 |
1969年 | 28392篇 |
1968年 | 26267篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
951.
Epidemiology of chlamydial eye diseases in a mixed rural/urban population of West Germany 总被引:1,自引:0,他引:1
4260 conjunctival specimens of 2850 outpatients with keratoconjunctivitis of presumed infectious etiology were studied. Two thousand six hundred sixty-eight specimens (63%) revealed growth of bacteria, and 80 (2%) growth of fungi. One hundred ninety-nine specimens (5%) were McCoy cell culture or direct stain (monoclonal antibody or Giemsa) positive for Chlamydia trachomatis. two patients had a C. psittaci infection (ELISA techniques). In patients with keratoconjunctivitis of bacterial etiology, overall incidence of McCoy cell culture-proven chlamydial infections was 7%; in the 20 to 30-year age group it was 12.5%. Simultaneous infections of chlamydiae and other bacteria were seen in 34 patients. Since sensitive and specific tests to diagnose chlamydial infections are available, ophthalmologists may be able to prevent these infections by agent-specific antibiotic therapy. 相似文献
952.
The Brief Symptom Inventory (BSI), a 53-item psychiatric symptom checklist, was administered to 57 alcoholic inpatients on days 2, 10, 18 and 26 of their 28-day stay in an alcoholism rehabilitation unit at a Veterans Administration hospital. The results of the test show a steady decline in the patients' psychiatric symptomatology from week 1 to week 4 with the most dramatic improvement evidenced between weeks 1 and 2. 相似文献
953.
R W Wulkan L Zwang T L Liem B G Blijenberg B Leijnse 《Zeitschrift für klinische Chemie und klinische Biochemie》1987,25(10):719-722
An expert system for evaluation of X-ray diffraction patterns of urinary calculi is described and evaluated. The software was developed using the PERSONAL CONSULTANT expert system shell from Texas Instruments. 相似文献
954.
955.
Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species. 总被引:7,自引:4,他引:3 下载免费PDF全文
J P O''''Keefe F R Venezio C A DiVincenzo K L Shatzer 《Antimicrobial agents and chemotherapy》1987,31(12):2002-2004
The in vitro activities of beta-lactam antibiotics against Bacteroides fragilis and B. fragilis group isolates are presented. Clinical isolates from 1986 were compared with strains from 1979 to 1982. Imipenem, ticarcillin-clavulanic acid, and ceftizoxime were the most active agents. Cefotetan was equivalent to cefoxitin against B. fragilis but less active against B. fragilis group isolates. Enhancement of cefotaxime by its desacetyl metabolite was minimal. 相似文献
956.
957.
958.
Malignant mixed müllerian tumor of the fallopian tube is an extremely rare neoplasm, with less than 30 cases reported. Clinical signs and symptoms are usually nonspecific and include lower abdominal pain, fever, and vaginal bleeding. The age at diagnosis varies from 14 to 76 years, with a mean of 55 years. Prognosis is poor, with only one woman surviving more than five years. Surgery is the treatment of choice, although chemotherapy may be of some benefit. 相似文献
959.
Patients with Fabry disease on dialysis in the United States. 总被引:9,自引:0,他引:9
Ravi Thadhani Myles Wolf Michael L West Marcello Tonelli Robin Ruthazer Gregory M Pastores Gregorio T Obrador 《Kidney international》2002,61(1):249-255
BACKGROUND.: Fabry disease results from an X-linked deficiency of lysosomal alpha-galactosidase A and is a rare cause of end-stage renal disease. Little is known about the characteristics of patients with Fabry disease that initiate dialysis in the United States, although data from Europe suggests these individuals have a poor survival. METHODS.: Using the United States Renal Disease System database, we first studied in detail 42 Fabry patients who initiated dialysis between April 1995 (following the introduction of the new detailed HCFA 2728 form) and July 1998. To examine crude survival in a larger cohort, 95 Fabry patients were studied who initiated dialysis between 1985 and 1993, similar to the European Registry. Diabetic and non-diabetic controls matched by age, gender, race, year of dialysis initiation, and initial dialysis modality were examined for comparison. RESULTS.: During the years 1995 to 1998, the mean age of Fabry patients that initiated dialysis was 42 years, 83% were Caucasian, and 10% were African American. Despite the X-linked inheritance of Fabry disease, 12% of Fabry patients on dialysis were female. At initiation of dialysis mean serum albumin and creatinine were significantly higher and mean body mass index was significantly lower among Fabry patients, but mean glomerular filtration rate was similar to controls. Fabry patients tended to have a lower three-year survival compared to non-diabetic controls, but the results were not significantly different. In a larger cohort of Fabry patients who initiated dialysis between 1985 and 1993, the three-year survival of Fabry patients was significantly lower than non-diabetic controls: 63% (95% CI, 50 to 75%) versus 74% (95% CI, 67 to 80%; P=0.03). CONCLUSION.: End-stage renal disease is associated with significant morbidity and mortality among patients with Fabry disease. Recent evidence that progression of Fabry disease may be attenuated by enzyme replacement therapy necessitates increased awareness of Fabry disease and its comorbidities. 相似文献
960.